Abstract Sodium arsenite exposure at concentration [5 lM may induce embryotoxic and teratogenic effects in animal models. Long-term health effects of sodium arsenite from contaminated drinking water may result in different forms of cancer and neurological abnormalities. As cancer development processes seem to be originated in stem cells, we have chosen to examine the effects of sodium arsenite on signaling pathways and the corresponding transcription factors that regulate cell viability and self-renewal in mouse embryonic stem cells (ESC) and mouse neural stem/ precursor cells. We demonstrated that the crucial signaling pathway, which was substantially suppressed by sodium arsenite exposure (4 lM) in ESC, was the PI3K-AKT pathway linked with numerous downstream targets that control cell survival and apoptosis. Furthermore, the whole core transcription factor circuitry that control self-renewal of mouse ESC (Stat3-P-Tyr705, Oct4, Sox2 and Nanog) was strongly down-regulated by sodium arsenite (4 lM) exposure. This was followed by G2/M arrest and induction of the mitochondrial apoptotic pathway that might be suppressed by caspase-9 and caspase-3 inhibitors. In contrast to mouse ESC with very low endogenous IL6, mouse neural stem/precursor cells (C17.2 clone immortalized by v-myc) with high endogenous production of IL6 exhibited a strong resistance to cytotoxic effects of sodium arsenite that could be decreased by inhibitory anti-IL6 antibody or Stat3 inhibition. In summary, our data demonstrated suppression of self-renewal and induction of apoptosis in mouse ESC by sodium arsenite exposure, which was further accelerated due to simultaneous inhibition of the protective PI3K-AKT and Stat3-dependent pathways.
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Introduction
Arsenic contamination of drinking water is a major environmental problem that affects more than 100 millions of people worldwide. Long-term health effects of inorganic sodium arsenite may result in different forms of cancer and neurological abnormalities [1, 2] . Furthermore, sodium arsenite is a well-characterized teratogen in animal models inducing a general embryotoxicity and causing a substantial disruption in embryonic neurogenesis [3] . However, the precise molecular mechanisms of these effects are still uncertain. Sodium arsenite at high doses ([10 lM) represents a general cell poison acting in two directions. As a sulfhydryl reagent, arsenite binds to the free thiol (-SH) groups of numerous enzymes inhibiting their activities and also significantly decreasing levels of glutathione (GSH) that further destroys the protective cellular functions [4] . As an inducer of production of reactive oxygen species, sodium arsenite causes oxidative stress, mitochondrial damage and a broad range of pathological conditions. These complementary negative effects of sodium arsenite finally result in the induction of cell death [5] [6] [7] [8] . On the other hand, chronic sodium arsenite exposure, which occurred in most cases at low doses (1-5 lM), could notably affect signaling pathways and substantially changing gene regulation in cells, including probably signaling and gene regulation in stem cells. Sodium arsenite is well-documented human carcinogen at these doses in drinking water [2] . As cancer development processes seem to be originated in stem cells [9] , we have chosen to examine the effects of sodium arsenite on stem cell viability and self-renewal capacity.
The self-renewal of embryonic stem cells (ESC) and the maintenance of their pluripotency are dependent on multifactorial stimulation of the cell signaling pathways by certain combinations of cytokines and growth factors that control ''stemness''-specific gene expression. Even though the combinations of the extrinsic factors are quite different for mouse and human ESC, their downstream targets include similar sets of genes, which encode transcription factors Oct4, Sox2, Nanog, Klf4 and cMyc, the key regulators of pluripotency of ESC [10, 11] . For mouse ESC in culture, external signaling molecules, such as the cytokine leukemia inhibitory factor (LIF) and several growth factors, BMP4, IGF1/2 and Wnt, regulate their self-renewal and pluripotency. Numerous investigations revealed a ''minimal'' combination of LIF-dependent [12, 13] and BMP-dependent signals [14] , which integrate with core transcriptional networks and control the maintenance and proliferation of mouse ESC together with a dynamic inhibition of the differentiation pathways [15] [16] [17] . The critical pathways, which regulate the self-renewal of mouse ESC and control gene expression of the core transcription factors, are initiated by LIF: LIF-(LIFR/gp130)-JAK2-Stat3 and LIF-(LIFR/gp130)-PI3K-AKT, where gp130 is the common signal transduction receptor protein of the IL6 family [13] . The relative pathways could also be initiated by IGF1/IGFR1 or EGF/EGFR. Furthermore, LIF-(LIFR/p130)-Ras-Raf-MEK-MAPK [13] and EGF/EGFR-Ras-Raf-MEK-MAPK signaling pathways are in dynamic crosstalk with Stat3-and AKT-pathways based on mutual interference [15, 16] . In contrast, the BMP-Smad1 pathway appears to suppress differentiation programs of ESC [17] .
Experiments with overexpression of gene combinations, encoding specific transcription factors, after retroviral infection of the corresponding cDNA in ESC established several sets of genes: Oct4, Sox2, cMyc and Klf2 [18, 19] ; Oct4, Sox2, Lin28 and Nanog [20] ; Oct4, Sox2, Klf4 and Tbx [21] , which could induce reprogramming fibroblasts to pluripotency. The triumvirate of transcription factors Oct4, Sox2 and Nanog plays the fundamental role in gene regulation, often binding multiple closely localized sites in the regulatory regions of the genome, creating enhanceosomes and coordinating expression of numerous genes in ESC. Smad1, Stat3 and the coactivator p300 appear to be additional components of enhanceosomes [17, 22] .
The main hypothesis, which had been addressed in the present study, was that sodium arsenite might directly target numerous signaling pathways in ESC, suppressing self-renewal and promoting apoptosis. To prove our hypothesis, we elucidated the effects of sodium arsenite exposure on signaling pathways in mouse ESC with a special attention to regulation of expression levels of key transcription factors Oct4, Sox2 and Nanog.
During embryogenesis, sodium arsenite, which is known as transplacental carcinogen [23] , might affect survival and proliferation of different types of stem/precursor cells, including embryonic neural stem/precursor cells, which can differentiate into the cells in the nervous system. We have further suggested in the present study that sodium arsenite exposure might target the embryonic neurogenesis in mice via interference and interaction with cell signaling pathways in mouse neural stem/precursor cells. We also elucidate a possible mechanism of the resistance to apoptotic death induced by sodium arsenite in neural stem/ precursor cells based on the IL6-Stat3 pathway.
Results
Sodium arsenite treatment modulates signaling pathways that control self-renewal and survival of mouse ESC In mouse ESC exposed to graded doses of sodium arsenite (1-6 lM, 24-48 h), there was a dramatic dose-dependent reduction in cell survival as shown in Fig. 1 . Phase contrast microscopy of live cell cultures demonstrated a massive flotation of ESC (24-48 h after treatment) that was accompanied by cell death (Fig. 1a) . Annexin-V-FITC and PI staining of control and sodium arsenite treated ES cells revealed an increase in percentage of Annexin-V-FITCpositive apoptotic cells (most of which were also PIpositive) 12 h after treatment with the coincident increase in the subpopulation of the secondary necrotic (Annexin-V-FITC-negative, PI-positive) cells (Fig. 1b) . Simultaneously, we observed significant changes in expression levels of hallmark proteins that control cell survival and apoptosis, such as a upregulation of the protective enzyme, heme oxygenase-1 (HO-1), that linked with massive heme inactivation after cytochrome-c release from mitochondria, transcription factor FOXO3A (as a sensor of oxidative stress), p21-WAF (as an indicator of the cell cycle arrest) and, finally, caspase-3-mediated PARP-1 cleavage (as an indication of irreversible apoptotic commitment) (Fig. 1c) .
FACS assays of PI-stained nuclei revealed strong dosedependent changes in cell cycle regulation for stem cells that resulted in G2/M arrest 24 h after arsenic treatment followed by pronounced apoptosis 48 h after treatment (Fig. 1d-f ). As expected, total levels of cell death were higher, than apoptotic levels after sodium arsenite exposure of mouse ESC, due to induction of necrosis (Fig. 1d) . A relative resistance of normal cells, including embryonic fibroblasts, to the cytotoxic effects of sodium arsenite at low doses (\5 lM) is well-known phenomenon [24] , which allows us to use arsenic for treatment of sensitive types of cancer without strong cytotoxicity for normal cells [25, 26] . On the other hand, a higher sensitivity of ESC to arsenic exposure described in the present study increases our understanding of risks linked with such treatment. Sodium arsenite (especially at doses [5 lM) could directly target mitochondria causing mitochondrial damage, cytochrome-c release to the cytoplasm and initiating the caspase-9-mediated mitochondrial death pathway [27, 28] . We used a pan-caspase inhibitor zVAD-fmk (50 lM) and specific caspase-9 inhibitor Ac-LEHD-CHO (50 lM), to obtain further evidences of activation of the mitochondrial apoptotic pathway in mouse ESC after arsenite treatment. Both inhibitors, zVAD-fmk and Ac-LEHD-CHO, notably suppressed apoptotic death induced by 1-4 lM sodium arsenite, while for higher arsenic concentration their inhibitory effects were not pronounced ( Fig. 1f) indicating on increased levels of non-apoptotic cell death. Caspase-8 inhibitor Ac-IETD-CHO did not exhibit substantial effects on apoptosis in ESC (data not shown), further highlighting a role for induction of the mitochondrial apoptotic pathway after sodium arsenite treatment [28, 29] .
In contrast to many cancer cell lines, transfer of ES cells to the restricted media (with 1 % FBS but without LIF) rapidly induced cell floating and high levels of cell death by apoptosis (Fig. 2b, c) . In the presence of sodium arsenite (2 lM), already high levels of spontaneous apoptotic death of ES cells grown in 1 % FBS were only modestly elevated (Fig. 2b, c) . On the other hand, a combination of less restricted media (with 7.5 % FBS, without LIF) and sodium arsenite demonstrated additive increase in apoptotic levels of ECS (Fig. 2b) . Combined treatment notably changed the protein levels of FGFR1 and EGFR, but not IGFR1, which could further down-regulate activating signaling in ESC at the late time points (Fig. 2a) . In summary, these observations indicated that sodium arsenite exposure and growth factor withdrawal had the same final destination, induction of apoptosis, which could be mediated by the similar signaling pathways.
Sodium arsenite exposure of ESC in the complete media induced a transient activation of JNK and c-Jun that was characteristic for the relatively early time point of 3-6 h after treatment and was followed by gradual down-regulation of JNK activity (Fig. 3a) . On the other hand, the PI3K-AKT connection, a cross-road of signaling pathways induced by activated growth factor receptor protein kinases (such as IGFR and EGFR) or by LIF receptor complex, plays a central role for a general cell survival and antiapoptotic protection [30] . Our experiments demonstrated negative properties of sodium arsenite treatment on the late AKT activation (16-24 h of exposure) via inhibition of its Ser473 phosphorylation (Fig. 3a, b) . As expected, suppression of AKT after 16 h of arsenic exposure was also accompanied by down-regulation of protein expression levels of b-catenin (Fig. 3a) that could be protected from degradation via AKT-mediated inactivation of GSK3b [31] . We and others previously reported a negative regulation of Jak2/Stat3 in normal and cancer cells by sodium arsenite treatment [26, 32] . We further demonstrated the negative effects of sodium arsenite treatment on Stat3 activation via Tyr705 phosphorylation in mouse ESC (Fig. 3a) . Since LIF-Jak2-Stat3 activation is crucial for ESC proliferation and survival [12, 13] , negative effect of sodium arsenite exposure on Stat3 activation are significant for acceleration of arsenite-induced apoptosis in ESC. Furthermore, sodium arsenite exposure persistently upregulated already high basal levels of MEK-dependent ERK1/ 2 activity. In contrast to JNK activation, high levels of active phospho-ERK1/2 were detected in ESC even 16 h after treatment (Fig. 3a) .
Protein levels of transcription factors Oct4, Sox2 and Nanog, which together with Stat3 and c-Myc were assembled in the core transcription factor circuitry of ESC [12] , started to decrease in dose-dependent manner 6 h after sodium arsenite treatment; this decrease was well pronounced 16 h after treatment (Fig. 3a) . It reflected a new balance between expression of genes, encoding Oct4, Sox2 and Nanog, and the corresponding protein degradation that was established in conditions of sodium arsenite exposure. Quite surprisingly, total p53 levels were relatively stable after sodium arsenite exposure (Fig. 3a) without a notable effect on its Ser15/Ser20 phosphorylation (data not shown). We also did not observe any substantial effects of low doses (2-4 lM) of sodium arsenite on IKK activation via suppression of its phosphorylation, as well as on the subsequent IjBa phosphorylation mediated by IKKb in ESC. Even though BMS345541 (10 lM), a specific inhibitor of the IKK-NF-jB pathway, demonstrated strong negative effects in ESC and finally down-regulated levels of the nuclear NF-jB p65-(phospho-Ser536) subunit (Fig. 3c ).
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activity, on activation of PI3K-AKT. PD152035, an inhibitor of EGFR kinase activity, as well as LY294002, an inhibitor of PI3K, exhibited similar effects that finally coincided with effects of sodium arsenite 24 h after treatment (Fig. 3b) . As expected, MEK-ERK activation was also dependent from activation of both IGF1R-and especially EGFR-dependent signaling pathways, as was shown by negative effects of specific upstream inhibitors, PPP and PD152035, on these signaling pathways. Small molecule inhibitor of MEK, U0126 (10 lM), blocked MEK-ERK activation that was opposite to arsenite action (Fig. 3b , the bottom panel).
To further evaluate effects of sodium arsenite on cell signaling, we compared its action with effects of specific molecule inhibitors on regulation of the cell cycle and apoptosis in ESC. The rapid response with pronounced induction of apoptosis in ESC was observed for LY294002 (40 lM), a PI3K-AKT inhibitor, and BMS345541 (10 lM), an IKK-NF-jB inhibitor (Fig. 4a, b) . Furthermore, PPP and PD153035, inhibitors of IGF-1R and EGFR kinase activity, respectively, and upstream suppressors of AKT activation, induced strong changes in the cell cycle distribution and high levels of apoptosis (Fig. 4a, b) . Inhibition of Stat3 with Stat3-inhibitor-6 (50 lM) also resulted in notably increased levels of apoptosis (Fig. 4b) . In contrast, suppression of MEK-ERK by U0126 increased G1 arrest and induced a modest apoptosis. SP600125, a JNK inhibitor, and SB203580, a MAPK p38 inhibitor, did not increase basal levels of apoptosis (Fig. 4b) . Caspase-3-dependent cleavage of PARP-1 provided a further proof of apoptotic commitment in ESC induced by LY294002 and BMS345541 (Fig. 4c) . Taken together, these data indicated that suppression of PI3K-AKT and Stat3-mediated signaling by sodium arsenite treatment of ESC could be critical for deregulation of the cell cycle and the subsequent apoptosis.
Inhibition of IKK-NF-jB also substantially decreased survival of ESC (Fig. 4a, b) . A general protective function of NF-jB in embryogenesis, especially in neurogenesis, is well known [33] . However, sodium arsenite treatment at low doses did not notably affect the NF-jB pathway and NF-jB-dependent transcription in ESC (see Fig. 3c ). In contrast to numerous cancer lines, the NF-jB pathway in ESC probably does not critically involve regulation of the resistance to sodium arsenite. Interestingly, the summary effects of sodium arsenite treatment on regulation of the ESC cell cycle-apoptosis were quite similar to an upstream inhibition of IGR1/IGF1R-mediated signaling by PPP. Related results with final induction of apoptosis were also obtained after EGF/EGFR inhibition (Fig. 4a, b) . Quite surprisingly, that in spite of common downstream targets, suppression of either IGFR1 or EGFR resulted in pronounced apoptosis in ESC, indicating incomplete interchangeability of the signaling pathways initiated by these receptor protein kinases.
Next, we evaluated effects of a relatively low dose of sodium arsenite (2 lM) in combination with inhibitors of signaling pathways on self-renewal and apoptosis in mouse ESC, as well as on protein expression levels of key transcription factors, Oct4, Sox2 and Nanog. Treatment of ESC with sodium arsenite (2 lM) in combination either with LY294002, or with BMS345541 additively increased . Error bars represent means ± SD (p \ 0.05, Student's t test). Total death levels were determined by cell counting using trypan blue staining and light microscopy. c Western blot analysis of caspase-3-dependent PARP-1 cleavage was performed 24 h after exposure to indicated inhibitors. b-Actin was used as a loading control. d Cell cycle-apoptosis analysis of mouse ESC 48 h after treatment with specific molecule inhibitors of cell signaling in the presence or in the absence of sodium arsenite (2 lM); control cultures were treated with 0.1 % DMSO alone or in combination with sodium arsenite. Error bars represent means ± SD (p \ 0.05, Student's t test). e, f Western blot analysis of protein expression levels 24 h after treatment of mouse ESC with sodium arsenite (2 lM), LY294002 (40 lM), BMS345541 (10 lM) alone or in combination apoptotic levels, achieving or surpassing levels induced by 6 lM sodium arsenite alone (Fig. 4d) . Some enhancing effects on arsenite-induced apoptosis were observed with U0126 and Stat3-inhibitor-6, while SP600125 and SB203580 did not exhibit notable effects (Fig. 4d) .
LY294002 alone or in combination with sodium arsenite (2 lM) strongly decreased protein levels of Nanog (Fig. 4e) . Positive regulation of Nanog expression by PI3K-AKT signaling via inhibition of GSK3 was previously described [34] . In contrast, LY294002 and sodium arsenite (2 lM) only modestly decreased Oct4 and Sox2 levels, acting alone or in combination. On the other hand, additive negative effects of LY294002 and sodium arsenite were observed for b-catenin protein levels, highlighting again a role of PI3K-AKT-GSK3b in stabilization of b-catenin protein levels and a role of sodium arsenite as an inhibitor of this pathway (Fig. 4e) .
BMS345541 alone or especially in combination with sodium arsenite (2 lM) strongly decreased Oct4 protein expression, revealing a possible role of IKK-NF-jB (in concert with other transcription factors) for control of Oct4 expression. Both agents also decreased Sox2 levels, but without additive effects in combination (Fig. 4f) . On the other hand, upregulation of transcription factor FOXO3A protein levels induced by sodium arsenite was not affected by simultaneous BMS345541 treatment (Fig. 4f) . Results obtained exhibited relatively mild effects of lower doses of sodium arsenite (1-2 lM) on key transcription factors in ESC; however, an increase in concentration of sodium arsenite (up to 4-6 lM) resulted in a significant downregulation of the levels of key transcription factors, Oct4, Sox2 and Nanog (see Fig. 3 ). So, protein levels of b-catenin, Nanog and Oct4 were under control of the PI3K-AKT pathway; furthermore, Oct4 and Sox2 levels were also dependent from IKK-NF-jB in mouse ESC. Combinations of sodium arsenite (2 lM) with either LY294002 or BMS345541 demonstrated additive suppression of b-catenin and Oct4 levels, respectively.
We also evaluated a role for mTOR in response of ESC to arsenic exposure. Activation of mTOR, a key regulator of protein synthesis in the cell, is a well-known downstream effect of the PI3K-AKT pathway [35] . Our data further demonstrated negative effects of sodium arsenite treatment (24-48 h) on the late AKT activation through inhibition of Ser473 phosphorylation and the subsequent down-regulation of its downstream target, mTOR activation, in ESC 24 h after treatment (Fig. 5a, b) . We also expected that sodium arsenite-mediated suppression of mTOR activity was critically involved in the regulation of arsenite-induced apoptosis. Surprisingly, rapamycin (1-5 nM), a specific inhibitor mTOR activity, induced G1 arrest of the ESC proliferation, rather than apoptosis (Fig. 5b) . It probably indicated a significance of other downstream targets of AKT in regulation of anti-apoptotic response.
In summary, our data demonstrated profound, but differential effects of sodium arsenite exposure on cell signaling pathways regulating the cell cycle, general cell survival and apoptosis in mouse ESC, balancing between cell cycle arrest, apoptosis and differentiation.
Effects of sodium arsenite exposure on immortalized mouse neural stem/progenitor cells (clone C17.2)
We used in our study surrogate mouse neural stem/progenitor cells (C17.2), which were isolated from neonatal mouse cerebellum. Propagation and stem-like behavior of this cell line was augmented via v-myc transduced by MMLV retrovirus vector [36] . Interestingly, the DNA profile of these cells, which were stained with PI, indicated a high level of aneuploidy (Fig. 6a) . It was correlated with results of the former study that detected aneuploidy in C17.2 cells using chromosome staining [37] . Unexpectedly, our data demonstrated a high resistance of C17.2 cells to sodium arsenite-induced apoptosis in culture conditions: modest apoptotic levels were detected only 48 h after arsenite treatment at dose 8 lM (Figs. 6c, 7a) . A recent study also proven anti-apoptotic resistance of C17.2 cells, demonstrating pronounced apoptosis at extremely high doses of sodium arsenite, such as 40 lM [38] . In contrast, LU294002, a PI3K-AKT inhibitor, and two upstream inhibitors of PI3K-AKT signaling, PPP and PD153035, were able to induce pronounced apoptosis in C17.2 cells 48 h after treatment (Fig. 6c) . As expected, total cell death levels were higher than apoptotic levels in treated C17.2 cells (Fig. 6c) . Western blot assay revealed very high basal levels of active ERK1/2, which were further upregulated by arsenite, but modest levels of active AKT-phospho-Ser473 that were downregulated by sodium arsenite exposure. It was accompanied by a partial suppression of GSK3b phosphorylation and relatively modest down-regulation of b-Catenin protein levels (Fig. 5b) . Inducible expression of HO-1, a hallmark protective enzyme, served as an internal control of initiation of arsenite-dependent intracellular activities (Fig. 6b) . What was a reason for substantial resistance of C17.2 cells to sodium arsenite treatment? Previously performed profiling of gene expression in C17.2 cells demonstrated massive changes in gene expression, including increased production of IL6 in this cell line, compared to the primary mouse neural stem cells [37] . Mouse ESC, which are critically dependent on the exogenous LIF, an IL6-related cytokine, also produce very low levels of the endogenous IL6 [39] . We further confirmed these data detecting the high basal and TNFa-induced levels of IL6 secretions in the culture media of C17.2 cells, compared to MEF or ESC (Fig. 6b) . Addition of anti-IL6 Cells were stained by propidium iodide and analyzed by the flow cytometry. Total cell death levels were determined using Trypan blue staining inhibitory mAb (5 lg/ml) into the culture media substantially increased levels of sodium arsenite-induced apoptosis in C17.2 cells (Fig. 7c) , highlighting a protective effect of the endogenous production of IL6. Since IL6 is a powerful inducer of Stat3 activation, we further treated C17.2 cells with Stat3-inhibitor-6 (20 lM) alone or in combination with sodium arsenite, significantly increasing the basal and arsenite-induced levels of apoptosis (Fig. 7d) . It also demonstrates a protective role of IL6-induced Stat3 activation against arsenite-induced apoptosis. Taken together, our results and published data allow us to consider C17.2 cells as model line with a strong resistance to sodium arsenite exposure in vitro, due to upregulation of IL6-Stat3-dependent signaling.
Discussion
A positive role of the PI3K-AKT pathway in regulation of embryonic stem cell and neural stem cell self-renewal has been well established [34, [40] [41] [42] . Two specific targets of this pathway are the ''stemness'' factors Nanog and Oct4 in mouse ESC [34] . Furthermore, the PI3K-AKT pathway is involved in regulation of numerous cell functions, including activation of mTOR that regulates a general protein synthesis in the cell [35] . A significance of PI3K-AKT/ b-catenin and Wnt/b-catenin signaling in the maintenance of self-renewal of ESC and NSC cells was also elucidated in detail [43, 44] . Suppression of GSK3b activity by AKT that resulted in stabilization of protein levels of b-catenin and cyclin D1 was one of the critical events in regulation of proliferation and survival of neural stem cells [45] . There is no surprise that cancer cells do use the same strategy for increasing proliferation and survival based on activation of the PI3K-AKT pathway [46] .
The results of the present study also indicated that one of the main and common targets for negative regulation by sodium arsenite was the PI3K-AKT pathway in both mouse ESC and NSC. Consequently, the current data and previous studies demonstrated that efficient protection against sodium arsenite action in ESC, NSC and in numerous cancer cell lines might be achieved by over-activation of the PI3K-AKT pathway [41, 47] . This pathway could be permanently induced in cells by variety of growth factors and cytokines, such as LIF, FGF2, EGF and IGF1/2, which could be present in the complete media in vitro, by these growth factors produced by helper cells of microenvironment or by endogenously produced growth factors via cell paracrine and autocrine mechanisms in vivo. In contrast, a general inhibition of the PI3K-AKT pathway by LY294002 or by sodium arsenite (but not mTOR inhibition) induced pronounced apoptosis that was additively increased by combined treatment using both agents. Arsenite-induced mitochondrial damage, the subsequent cytochrome-c release and caspase-9/caspase-3 mediated apoptosis could substantially decrease a survival of mouse ESC after sodium arsenite exposure.
Effects of sodium arsenite on its downstream targets in ESC were further investigated in the present study. Besides negative regulation of targets of the PI3K-AKT pathway, such as Oct4 and Nanog, sodium arsenite exposure further down-regulated the Jak2-Stat3 pathway and its downstream targets, including Stat3/Oct4-dependent expression of Sox2 in ESC. It finally suppressed the whole core transcription factor circuitry that control self-renewal of mouse ESC, including Stat3, Oct4, Sox2 and Nanog [12, 22] .
Negative regulation of IKK-NF-jB activities by sodium arsenite (5-10 lM) is a well-established phenomenon for many normal and cancer cell lines [48, 49] . However, for ESC investigated in the present study, sodium arsenite (2-4 lM) actually did not affect IKK-NF-jB activation, due to probably increased compensatory production of endogenous cytokines, including TNFa [50] that by itself was a powerful inducer of the NF-jB activation pathway. This problem, however, needs a more precise analysis, since numerous protein-protein interactions of key transcription factors, such as Stat3-NF-jB p65 [51] or Stat3-Nanog [52] could substantially complicate general regulation of NF-jB-dependent and Stat3-dependent gene expression in stem cells.
In contrast to ESC, immortalized mouse neural stem/ precursor cells C17.2 demonstrated a high resistance to sodium arsenite exposure (see Fig. 6c ). However, this situation is based on massive changes in gene regulation for immortalized mouse NSC (C17.2), compared to the primary neural stem cells, including strongly increased endogenous production of IL6 [37] . This reminds a correlation between N-Myc amplification/overexpression and a strong IL6 production by human neuroblastomas [24, 53] . Indeed, using anti-IL6 antibody, we increased a sensitivity of C17.2 cells to sodium arsenite-mediated apoptosis. Suppression of the main downstream signaling target of IL6, Stat3, by specific small molecule inhibitor also substantially upregulated arsenite-induced apoptosis in C17.2 cells (Fig. 7c, d ). Sodium arsenite was previously described as a twosided sword, which is a well-known human carcinogen and an effective therapeutic agent for treatment of some types of cancer, especially for treatment of acute promyelocytic leukemia [25] . Better understanding of mechanisms of cytotoxic action of sodium arsenite, for example, in the nervous system and narrowing the window of its specific effects for cancer, such as neuroblastoma [54] , is a priority for the development the anti-cancer therapy.
Materials and methods

Materials
Sodium arsenite, fibronectin, laminin and polyornithine were obtained from Sigma-Aldrich (St. Louis, MO, USA). PI3K inhibitor LY294002, IKK inhibitor BMS-345541, STAT3 inhibitor-6 S3I-201 (also known as NSC 74859), IGF-1R kinase inhibitor picropodophyllin (PPP), PI3K inhibitor LY294002, MEK inhibitor U0126, MAPK p38 inhibitor SB203580 and caspase inhibitors zVAD-fmk, LEHD and IETD were purchased from Calbiochem (La Jolla, CA, USA). Annexin-V-FITC was obtained from BD Bioscience (San Jose, CA, USA).
Maintenance of mouse ESC
We used in the present study ESC line W4 from 129/SvEvTac mice. Mouse ESC were grown in DMEM with 15 % FBS, 1 % glutamine, 1 % nonessential amino acids, 0.1 mM b-mercaptoethanol, and 10 5 U/ml LIF (ESGRO) on fibronectin coated dishes. 
Immunocytochemistry analysis
Cells were fixed with 4 % paraformaldehyde in PBS for 60 min. Immunochemical staining was performed using standard protocols. Cells were stained for the undifferentiated NSC marker, nestin (using mAb from Millipore, Temecula, CA, USA) and for localization of the nuclei using DAPI.
Apoptosis studies
For induction of apoptosis, cells were exposed to sodium arsenite (1-10 lM) alone or in the presence of small molecule inhibitors of cell signaling pathways. Apoptosis was then assessed by PI staining and quantifying the percentage of hypodiploid nuclei (pre-G1) or by quantifying the percentage of AnnexinV-FITC-positive cells, both PI-negative and PI-positive. Flow cytometric analysis was performed on a FACS Calibur flow cytometer (BectonDickinson) using the CellQuest program. Determination of total cell death levels was performed by Trypan blue staining.
Western blot analysis
Total cell lysates (50 lg protein) were resolved on SDS-PAGE, and processed according to standard protocols. The monoclonal antibodies used for western blotting included: anti-b-actin (Sigma, St. Louis, MO, USA); anti-caspase-8, anti-caspase-9, anti-caspase-3 (Cell Signaling, Danvers, MA, USA); The polyclonal antibodies used included antiphospho-p44/p42 MAP kinase (T202/Y204) and anti-p44/ p42 MAP kinase; anti-phospho-JNK and anti-JNK1-3; anti-phospho-cJun (S73) and anti-cJun; anti-phospho-AKT (S473) and anti-AKT; anti-phospho-p65 (S536) NF-jB and anti-p65 NF-jB, anti-phospho-STAT3 (Y705) and anti-STAT3; anti-phospho-FOXO3A (S253) and anti-FOXO3A; anti-b-Catenin, anti-Oct4, anti-Sox2, antiNanog and anti-PARP-1 (Cell Signaling, Danvers, MA, USA); anti-Ars2 (Santa Cruz Biotechnology, CA, USA); anti-HO-1 (Enzo Life Sciences, Plymouth Meeting, PA, USA). The secondary antibodies were conjugated to horseradish peroxidase; signals were detected using the ECL system (Thermo Scientific, Rockford, IL, USA).
ELISA
Antibody pair used in sandwich ELISA for this study is commercially available. Kit to detect IL6 was from Life Technologies/Invitrogen (Carlsbad, CA, USA).
Statistical analysis
Data from 3 to 4 independent experiments were calculated as means and standard deviations. Comparisons of results between treated and control groups were made by the Students' t-tests. A p value of 0.05 or less between groups was considered significant.
